Literature DB >> 20199210

A spinocerebellar ataxia family with expanded alleles in the TATA-binding protein gene and ataxin-3 gene.

Qian Xu1, Qinghua Li, Junling Wang, Hong Jiang, Lu Shen, Xiaohui Li, Beisha Tang.   

Abstract

We report on a Chinese family with three members who have CAG repeat expansion in the ataxin-3, two members present with expanded trinucleotide repeat in both the ataxin-3 and tata-binding protein (TBP) and an individual who carries expanded CAG/CAA repeat in the TBP. Only the patients who carry an allele with expansion in the ataxin-3 gene presented with clinical symptoms. This interesting family presents a unique mutation state. We will continue to track this family in the future, which may help us further elucidate the pathogenic mechanism of spinocerebellar ataxia (SCA) type 3 and 17. The study also provides us a novel conception that mutations from two pathogenetic genes may coexist in one patient and SCA-affected patients with intermediate allele need to be further excluded for other SCA subtypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20199210     DOI: 10.3109/00207450903389149

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  3 in total

1.  Spinocerebellar Ataxia 2 and 12 Mutations in an Indian Family with Cerebellar Ataxia and Slow Saccades.

Authors:  Mohammed Faruq; Sunil Shakya; Ajay Garg; Achal Kumar Srivastava
Journal:  Mov Disord Clin Pract       Date:  2014-07-31

2.  A Novel Co-existence of Spinocerebellar Ataxia 1 and Spinocerebellar Ataxia 2 Mutations in Indian Patients.

Authors:  Pooja Sharma; Akhilesh K Sonakar; Vinay Goel; Ajay Garg; Achal K Srivastava; Mohammed Faruq
Journal:  Mov Disord Clin Pract       Date:  2022-05-10

3.  Co-occurrence of ATXN3 and ATXN2 repeat expansions in Chinese ataxia patients with slow saccades.

Authors:  Chao Wu; Qiong Cai; Huajing You; Xiangxue Zhou; Dingbang Chen; Guiling Mo; Xunhua Li
Journal:  Mol Genet Genomic Med       Date:  2019-03-28       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.